IOVS Clinical Microbiology Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heiligenhaus, A.
Right arrow Articles by Tseng, S. C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heiligenhaus, A.
Right arrow Articles by Tseng, S. C. G.
(Investigative Ophthalmology and Visual Science. 2001;42:1969-1974.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Improvement of HSV-1 Necrotizing Keratitis with Amniotic Membrane Transplantation

Arnd Heiligenhaus1,2, Dirk Bauer1,2, Daniel Meller1,3, Klaus-Peter Steuhl1 and Scheffer C. G. Tseng3

1 From the Department of Ophthalmology, University of Essen, Germany; 2 Department of Ophthalmology, St. Franziskus Hospital, Muenster, Germany; and the 3 Department of Ophthalmology, Ocular Surface and Tear Center, Bascom Palmer Eye Institute, University of Miami School of Medicine, Florida.

PURPOSE. Stromal herpes simplex virus keratitis (HSK) is an immune-mediated disease. Previous studies have indicated that T cells, neutrophils, and macrophages contribute to the tissue damage in HSK. It has been shown that human amniotic membrane promotes epithelial wound healing and has diverse anti-inflammatory effects. In this study, the effect of amniotic membrane transplantation (AMT) on corneal wound healing and on inflammation in mice with necrotizing HSK was examined.

METHODS. BALB/c mice were corneally infected with 105 plaque-forming units (PFU) of HSV-1 (KOS strain). In 16 mice that exhibited severe ulcerating HSK, the cornea was covered with a preserved human amniotic membrane as a patch. Corneas in 16 infected mice remained uncovered and served as a control. On days 2 and 7 after surgery, the amniotic membrane was removed (eight mice in each group), the HSV-1–infected cornea was evaluated clinically, and the eye was enucleated. Tissue sections were analyzed histologically for epithelialization and cellular infiltration and immunohistochemically with anti-CD3 mAb to T cells, anti-CD11b mAb to both macrophages and neutrophils, or anti-F4/80 mAb to macrophages.

RESULTS. Profound regression of corneal inflammation and rapid closure of epithelial defects were observed clinically within 2 days in the amniotic membrane-covered eyes, whereas HSV-1 keratitis and ulceration progressed in all mice in the control group (P < 0.001). Histologically, corneal edema and inflammatory infiltration, and immunohistochemically the number of CD3+, CD11b+, and F4/80+ cells in the cornea were markedly decreased at 2 and 7 days after amniotic membrane application, compared with the uncovered control corneas (P < 0.001).

CONCLUSIONS. AMT promotes rapid epithelialization and reduces stromal inflammation and ulceration in HSV-1 keratitis. AMT in mice with HSV necrotizing stromal keratitis appears to be a useful model for investigating the effect and the action mechanism of human amniotic membrane.




This article has been cited by other articles:


Home page
IOVSHome page
H. He, W. Li, S.-Y. Chen, S. Zhang, Y.-T. Chen, Y. Hayashida, Y.-T. Zhu, and S. C. G. Tseng
Suppression of Activation and Induction of Apoptosis in RAW264.7 Cells by Amniotic Membrane Extract
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4468 - 4475.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
A. Kheirkhah, D. A. Johnson, D. R. Paranjpe, V.K. Raju, V. Casas, and S. C. G. Tseng
Temporary Sutureless Amniotic Membrane Patch for Acute Alkaline Burns
Arch Ophthalmol, August 1, 2008; 126(8): 1059 - 1066.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. S. Barequet, Z. Habot-Wilner, N. Keller, G. Smollan, H. Ziv, M. Belkin, and M. Rosner
Effect of Amniotic Membrane Transplantation on the Healing of Bacterial Keratitis
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 163 - 167.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C.-C. Sun, J.-H. Su Pang, C.-Y. Cheng, H.-F. Cheng, Y.-S. Lee, W.-C. Ku, C.-H. Hsiao, J.-K. Chen, and C.-M. Yang
Interleukin-1 Receptor Antagonist (IL-1RA) Prevents Apoptosis in Ex Vivo Expansion of Human Limbal Epithelial Cells Cultivated on Human Amniotic Membrane
Stem Cells, September 1, 2006; 24(9): 2130 - 2139.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Heiligenhaus, H. F. Li, Y. Yang, S. Wasmuth, K. P. Steuhl, and D. Bauer
Transplantation of Amniotic Membrane in Murine Herpes Stromal Keratitis Modulates Matrix Metalloproteinases in the Cornea
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4079 - 4085.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L.-K. Yeh, W.-L. Chen, W. Li, E. M. Espana, J. Ouyang, T. Kawakita, W. W.-Y. Kao, S. C. G. Tseng, and C.-Y. Liu
Soluble Lumican Glycoprotein Purified from Human Amniotic Membrane Promotes Corneal Epithelial Wound Healing
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 479 - 486.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Wasmuth, D. Bauer, Y. Yang, K.-P. Steuhl, and A. Heiligenhaus
Topical Treatment with Antisense Oligonucleotides Targeting Tumor Necrosis Factor-{alpha} in Herpetic Stromal Keratitis
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5228 - 5234.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A Heiligenhaus, H Li, E E Hernandez Galindo, J M Koch, K-P Steuhl, and D Meller
Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation
Br. J. Ophthalmol., October 1, 2003; 87(10): 1215 - 1219.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S.-E. Ti, D. Anderson, A. Touhami, C. Kim, and S. C. G. Tseng
Factors Affecting Outcome Following Transplantation of Ex vivo Expanded Limbal Epithelium on Amniotic Membrane for Total Limbal Deficiency in Rabbits
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2584 - 2592.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S. C G TSENG
Amniotic membrane transplantation for persistent corneal epithelial defect
Br. J. Ophthalmol., December 1, 2001; 85(12): 1400 - 1401.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology